Your browser doesn't support javascript.
loading
Programmed Cell Death Ligand Expression Drives Immune Tolerogenesis across the Diverse Subtypes of Neuroendocrine Tumours.
Pinato, David J; Vallipuram, Anu; Evans, Joanne S; Wong, Clement; Zhang, Hua; Brown, Matthew; Dina, Roberto E; Trivedi, Pritesh; Akarca, Ayse U; Marafioti, Teresa; Mauri, Francesco A; Sharma, Rohini.
Afiliação
  • Pinato DJ; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom, david.pinato@imperial.ac.uk.
  • Vallipuram A; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom.
  • Evans JS; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom.
  • Wong C; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom.
  • Zhang H; Department of Medical Oncology, LC-4112, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Brown M; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom.
  • Dina RE; Department of Histopathology, Imperial College London, Hammersmith Hospital, London, United Kingdom.
  • Trivedi P; Department of Histopathology, Imperial College London, Hammersmith Hospital, London, United Kingdom.
  • Akarca AU; Department of Histopathology, Rockefeller Building, University College London Hospital, London, United Kingdom.
  • Marafioti T; Department of Histopathology, Rockefeller Building, University College London Hospital, London, United Kingdom.
  • Mauri FA; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom.
  • Sharma R; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom.
Neuroendocrinology ; 111(5): 465-474, 2021.
Article em En | MEDLINE | ID: mdl-32097935

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Tumores Neuroendócrinos / Antígeno B7-H1 / Proteína 2 Ligante de Morte Celular Programada 1 / Receptor de Morte Celular Programada 1 / Células Neoplásicas Circulantes Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Neuroendocrinology Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Tumores Neuroendócrinos / Antígeno B7-H1 / Proteína 2 Ligante de Morte Celular Programada 1 / Receptor de Morte Celular Programada 1 / Células Neoplásicas Circulantes Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Neuroendocrinology Ano de publicação: 2021 Tipo de documento: Article